Asset Allocation

As of December 31, 2025.
Type % Net
Cash 7.31%
Stock 54.62%
Bond 33.54%
Convertible 0.00%
Preferred 0.03%
Other 4.50%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 88.08%
Mid 8.52%
Small 3.39%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 94.24%    % Emerging Markets: 0.05%    % Unidentified Markets: 5.71%

Americas 92.92%
92.88%
Canada 48.77%
United States 44.11%
0.04%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.25%
United Kingdom 0.27%
0.98%
France 0.23%
Germany 0.00%
Ireland 0.44%
Italy 0.14%
Netherlands 0.06%
Spain 0.11%
Switzerland 0.00%
0.00%
0.00%
Greater Asia 0.12%
Japan 0.10%
0.03%
Australia 0.03%
0.00%
Taiwan 0.00%
0.00%
Unidentified Region 5.71%

Bond Credit Quality Exposure

AAA 15.69%
AA 26.68%
A 9.97%
BBB 35.39%
BB 3.75%
B 0.03%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.17%
Not Available 8.32%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
36.61%
Materials
1.76%
Consumer Discretionary
6.92%
Financials
23.31%
Real Estate
4.62%
Sensitive
25.17%
Communication Services
0.06%
Energy
11.75%
Industrials
8.44%
Information Technology
4.92%
Defensive
10.23%
Consumer Staples
3.10%
Health Care
4.46%
Utilities
2.67%
Not Classified
27.99%
Non Classified Equity
0.66%
Not Classified - Non Equity
27.33%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 37.13%
Corporate 49.51%
Securitized 1.61%
Municipal 3.42%
Other 8.32%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.87%
Less than 1 Year
0.87%
Intermediate
73.67%
1 to 3 Years
23.73%
3 to 5 Years
11.32%
5 to 10 Years
38.63%
Long Term
23.59%
10 to 20 Years
3.63%
20 to 30 Years
13.33%
Over 30 Years
6.63%
Other
1.87%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial